Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Avanafil | Ferulic acid may increase the hypotensive activities of Avanafil. |
| Iloprost | Iloprost may increase the hypotensive activities of Ferulic acid. |
| Citalopram | The risk or severity of bleeding can be increased when Ferulic acid is combined with Citalopram. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Ferulic acid. |
| Levomilnacipran | The risk or severity of bleeding can be increased when Ferulic acid is combined with Levomilnacipran. |
| Venlafaxine | The risk or severity of bleeding can be increased when Ferulic acid is combined with Venlafaxine. |
| Oxaliplatin | The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ferulic acid. |
| Serdexmethylphenidate | The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Serdexmethylphenidate. |
| Padeliporfin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Padeliporfin. |
| Soybean oil | The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Soybean oil. |
| Olive oil | The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Olive oil. |
| Sodium ferric gluconate complex | The risk or severity of hypotension can be increased when Sodium ferric gluconate complex is combined with Ferulic acid. |
| Inotersen | The risk or severity of thrombocytopenia can be increased when Inotersen is combined with Ferulic acid. |
| Collagenase clostridium histolyticum | The risk or severity of adverse effects can be increased when Ferulic acid is combined with Collagenase clostridium histolyticum. |
| Apixaban | The risk or severity of adverse effects can be increased when Ferulic acid is combined with Apixaban. |
| Lepirudin | The risk or severity of bleeding can be increased when Lepirudin is combined with Ferulic acid. |
| Bivalirudin | The risk or severity of bleeding can be increased when Bivalirudin is combined with Ferulic acid. |
| Alteplase | The risk or severity of bleeding can be increased when Alteplase is combined with Ferulic acid. |
| Urokinase | The risk or severity of bleeding can be increased when Urokinase is combined with Ferulic acid. |
| Reteplase | The risk or severity of bleeding can be increased when Reteplase is combined with Ferulic acid. |
| Anistreplase | The risk or severity of bleeding can be increased when Anistreplase is combined with Ferulic acid. |
| Tenecteplase | The risk or severity of bleeding can be increased when Tenecteplase is combined with Ferulic acid. |
| Abciximab | The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid. |
| Drotrecogin alfa | The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Ferulic acid. |
| Streptokinase | The risk or severity of bleeding can be increased when Streptokinase is combined with Ferulic acid. |
| Dicoumarol | The risk or severity of bleeding can be increased when Dicoumarol is combined with Ferulic acid. |
| Argatroban | The risk or severity of bleeding can be increased when Argatroban is combined with Ferulic acid. |
| Ardeparin | The risk or severity of bleeding can be increased when Ardeparin is combined with Ferulic acid. |
| Phenindione | The risk or severity of bleeding can be increased when Phenindione is combined with Ferulic acid. |
| Fondaparinux | The risk or severity of bleeding can be increased when Fondaparinux is combined with Ferulic acid. |
| Warfarin | The risk or severity of bleeding can be increased when Warfarin is combined with Ferulic acid. |
| Pentosan polysulfate | The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Ferulic acid. |
| Phenprocoumon | The risk or severity of bleeding can be increased when Phenprocoumon is combined with Ferulic acid. |
| Edetic acid | The risk or severity of bleeding can be increased when Edetic acid is combined with Ferulic acid. |
| Dipyridamole | The risk or severity of bleeding can be increased when Dipyridamole is combined with Ferulic acid. |
| Heparin | The risk or severity of bleeding can be increased when Heparin is combined with Ferulic acid. |
| Enoxaparin | The risk or severity of bleeding can be increased when Enoxaparin is combined with Ferulic acid. |
| Epoprostenol | The risk or severity of bleeding can be increased when Epoprostenol is combined with Ferulic acid. |
| Acenocoumarol | The risk or severity of bleeding can be increased when Acenocoumarol is combined with Ferulic acid. |
| 4-hydroxycoumarin | The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Ferulic acid. |
| Coumarin | The risk or severity of bleeding can be increased when Coumarin is combined with Ferulic acid. |
| Ximelagatran | The risk or severity of bleeding can be increased when Ximelagatran is combined with Ferulic acid. |
| Desmoteplase | The risk or severity of bleeding can be increased when Desmoteplase is combined with Ferulic acid. |
| Defibrotide | The risk or severity of bleeding can be increased when Defibrotide is combined with Ferulic acid. |
| Ancrod | The risk or severity of bleeding can be increased when Ancrod is combined with Ferulic acid. |
| Beraprost | The risk or severity of bleeding can be increased when Beraprost is combined with Ferulic acid. |
| SR-123781A | The risk or severity of bleeding can be increased when SR-123781A is combined with Ferulic acid. |
| Prasugrel | The risk or severity of bleeding can be increased when Prasugrel is combined with Ferulic acid. |
| Rivaroxaban | The risk or severity of bleeding can be increased when Rivaroxaban is combined with Ferulic acid. |
| Sulodexide | The risk or severity of bleeding can be increased when Sulodexide is combined with Ferulic acid. |
| Semuloparin | The risk or severity of bleeding can be increased when Semuloparin is combined with Ferulic acid. |
| Idraparinux | The risk or severity of bleeding can be increased when Idraparinux is combined with Ferulic acid. |
| Cangrelor | The risk or severity of bleeding can be increased when Cangrelor is combined with Ferulic acid. |
| Astaxanthin | The risk or severity of bleeding can be increased when Astaxanthin is combined with Ferulic acid. |
| Otamixaban | The risk or severity of bleeding can be increased when Otamixaban is combined with Ferulic acid. |
| Amediplase | The risk or severity of bleeding can be increased when Amediplase is combined with Ferulic acid. |
| Dabigatran etexilate | The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Ferulic acid. |
| Danaparoid | The risk or severity of bleeding can be increased when Danaparoid is combined with Ferulic acid. |
| Dalteparin | The risk or severity of bleeding can be increased when Dalteparin is combined with Ferulic acid. |
| Tinzaparin | The risk or severity of bleeding can be increased when Tinzaparin is combined with Ferulic acid. |
| (R)-warfarin | The risk or severity of bleeding can be increased when Ferulic acid is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of bleeding can be increased when Ferulic acid is combined with Ethyl biscoumacetate. |
| Nadroparin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Nadroparin. |
| Triflusal | The risk or severity of bleeding can be increased when Ferulic acid is combined with Triflusal. |
| Ticagrelor | The risk or severity of bleeding can be increased when Ferulic acid is combined with Ticagrelor. |
| Ditazole | The risk or severity of bleeding can be increased when Ferulic acid is combined with Ditazole. |
| Vorapaxar | The risk or severity of bleeding can be increased when Ferulic acid is combined with Vorapaxar. |
| Edoxaban | The risk or severity of bleeding can be increased when Ferulic acid is combined with Edoxaban. |
| Sodium citrate | The risk or severity of bleeding can be increased when Ferulic acid is combined with Sodium citrate. |
| Limaprost | The risk or severity of bleeding can be increased when Ferulic acid is combined with Limaprost. |
| Dextran | The risk or severity of bleeding can be increased when Ferulic acid is combined with Dextran. |
| Bemiparin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Bemiparin. |
| Reviparin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Reviparin. |
| Parnaparin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Parnaparin. |
| Desirudin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Desirudin. |
| Antithrombin Alfa | The risk or severity of bleeding can be increased when Ferulic acid is combined with Antithrombin Alfa. |
| Protocatechualdehyde | The risk or severity of bleeding can be increased when Ferulic acid is combined with Protocatechualdehyde. |
| Protein C | The risk or severity of bleeding can be increased when Ferulic acid is combined with Protein C. |
| Antithrombin III human | The risk or severity of bleeding can be increased when Ferulic acid is combined with Antithrombin III human. |
| Letaxaban | The risk or severity of bleeding can be increased when Ferulic acid is combined with Letaxaban. |
| Darexaban | The risk or severity of bleeding can be increased when Ferulic acid is combined with Darexaban. |
| Betrixaban | The risk or severity of bleeding can be increased when Ferulic acid is combined with Betrixaban. |
| Nafamostat | The risk or severity of bleeding can be increased when Ferulic acid is combined with Nafamostat. |
| Monteplase | The risk or severity of bleeding can be increased when Ferulic acid is combined with Monteplase. |
| Gabexate | The risk or severity of bleeding can be increased when Ferulic acid is combined with Gabexate. |
| Troxerutin | The risk or severity of bleeding can be increased when Ferulic acid is combined with Troxerutin. |
| Fluindione | The risk or severity of bleeding can be increased when Ferulic acid is combined with Fluindione. |
| Protein S human | The risk or severity of bleeding can be increased when Ferulic acid is combined with Protein S human. |
| Brinase | The risk or severity of bleeding can be increased when Ferulic acid is combined with Brinase. |
| Clorindione | The risk or severity of bleeding can be increased when Ferulic acid is combined with Clorindione. |
| Diphenadione | The risk or severity of bleeding can be increased when Ferulic acid is combined with Diphenadione. |
| Tioclomarol | The risk or severity of bleeding can be increased when Ferulic acid is combined with Tioclomarol. |
| Melagatran | The risk or severity of bleeding can be increased when Ferulic acid is combined with Melagatran. |
| Saruplase | The risk or severity of bleeding can be increased when Ferulic acid is combined with Saruplase. |
| (S)-Warfarin | The risk or severity of bleeding can be increased when Ferulic acid is combined with (S)-Warfarin. |
| Tocopherylquinone | The risk or severity of bleeding can be increased when Ferulic acid is combined with Tocopherylquinone. |
| Dabigatran | The risk or severity of bleeding can be increased when Ferulic acid is combined with Dabigatran. |
| Dermatan sulfate | The risk or severity of bleeding can be increased when Ferulic acid is combined with Dermatan sulfate. |
| Trazodone | The risk or severity of bleeding can be increased when Trazodone is combined with Ferulic acid. |
| Triamcinolone | The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Triamcinolone. |